4-amino-N-benzylbenzenesulfonamide, 95.0%, 250mg

3-Methylbutane-1-sulfonyl chloride, 1g

Diethyl DL-Malate>98.0%(GC)500g

(S)-tert-Butyl 2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate, 95.0%, 25g

trans-4'-(p-Tolyl)-[1,1'-bi(cyclohexan)]-4-one>98.0%(GC)5g

2-Hydroxy-1-naphthaldehyde>98.0%(GC)(T)25g

4,4'-Oxydiphthalic acid, 97%, 5g

Olmutinib, 90%, 100mg

5-Ethynyl-dU-CEP, ≥90%, 250 mg, plastic packaging.

4-Methyl-2,6-dioxo-8-(thiophen-2-yl)hexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-ium-8-uide, 95.0%, 5g

3-Methyl-pyrrolidine hydrochloride, 97.0%, 50g

2,5-Dihydroxy-4-methylbenzaldehyde, 95.0%, 5g

2,7-Dimethyl-1H-indole, 1g